| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |